Holen Sie sich die Stockscreener-App
17.33
5.67%
0.93
Handel nachbörslich:
17.67
0.34
+1.96%
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx’s SWOT analysis: digital health firm’s stock faces scaling hurdles - Investing.com
JMP Securities Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript - Insider Monkey
JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $20.00 - MarketBeat
Is OptimizeRx Corporation stock bottoming outTechnical Trend Forecast for Investors - Newser
OptimizeRX price target raised to $20 from $14 at JMP on strong earnings - Investing.com Nigeria
Will breakout in OptimizeRx Corporation lead to full recoveryReal-Time Signal Tracking with Entry Level - Newser
What technical models suggest about OptimizeRx Corporation’s comebackDaily Stock Watch Summary with Key Insights - Newser
Can you recover from losses in OptimizeRx CorporationAI Short-Term Gain Forecast with Data - Newser
What makes OptimizeRx Corporation stock price move sharplySwing Trade Timing with Daily Forecast - Newser
Using AI based signals to follow OptimizeRx CorporationSteady Return Plan Based on Data Analysis - Newser
Trend analysis for OptimizeRx Corporation this weekFree Daily Growth Stock Pick Reports - Newser
Should you hold or exit OptimizeRx Corporation nowTechnical Screener for High Growth Stocks - Newser
Blair William & Co. IL Buys 29,648 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
Applying Elliott Wave Theory to OptimizeRx CorporationShort Term Gain Strategy with AI Logic - Newser
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN
Stifel Nicolaus Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - MarketBeat
Advanced analytics toolkit walkthrough for OptimizeRx CorporationTechnical Reversal Pattern Summary and Tracker - Newser
OptimizeRx Reports Strong Q2 2025 Financial Growth - The Globe and Mail
Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest
OptimizeRx Corp Surpasses Q2 2025 Estimates with 55% Revenue Increase, Achieves GAAP Net Income of $1.5M - AInvest
Stifel raises Optimizerx PT to $18, maintains Buy rating. - AInvest
Earnings call transcript: OptimizeRx Q2 2025 sees EPS surprise, stock jumps - Investing.com Nigeria
OptimizeRx Corp (OPRX) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
OptimizeRx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push - inkl
OPTIMIZERx earnings beat by $0.22, revenue topped estimates - Investing.com
OptimizeRx Q2 rev up 55% YoY to $29.2mln, raises FY25 guidance. - AInvest
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - The Manila Times
Press Release: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - 富途牛牛
Best Growth Stocks to Buy for August 7th - TradingView
Technical analysis overview for OptimizeRx Corporation stockTrend Reversal Watch with Entry Signals - Newser
Has OptimizeRx Corporation formed a bullish divergenceEntry Opportunity Screener with Confirmation - Newser
OptimizeRx Corp expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Best Growth Stocks to Buy for August 5th - TradingView
OptimizeRx (OPRX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Is OptimizeRx Corporation stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News
Why is OptimizeRx Corporation stock attracting strong analyst attentionMaximize returns with strategic stock selection - Jammu Links News
How volatile is OptimizeRx Corporation stock compared to the marketMaximize returns with timely market signals - Jammu Links News
Should I hold or sell OptimizeRx Corporation stock in 2025Get real-time alerts on high-potential stocks - Jammu Links News
Best Growth Stocks to Buy for August 1st - Yahoo Finance
Published on: 2025-08-01 01:36:35 - Newser
Bull Of The Day: OptimizeRX (OPRX) - The Globe and Mail
Does OptimizeRx Have a Moat in the Crowded HealthTech Space? - Yahoo Finance
11.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):